Form 4: Cullinan Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Jacquelyn L. Sumer, Chief Legal Officer of Cullinan Therapeutics, Inc., sold 3,482 shares of common stock on December 18, 2024, to cover personal income tax obligations.
Summary
- On December 18, 2024, Jacquelyn L. Sumer, the Chief Legal Officer of Cullinan Therapeutics, Inc., sold 3,482 shares of the company's common stock.
- The sale was executed at a price of $11.41 per share.
- This transaction was conducted to cover personal income tax obligations arising from the vesting of restricted stock units.
- Following the sale, Sumer directly owns 90,651 shares of Cullinan Therapeutics.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing simply reports a routine stock sale for tax purposes. It doesn't indicate any particular positive or negative outlook for the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common reason for such transactions.
Stakeholder Impact
- The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 12/18/2024 | Date of the stock sale transaction. |
| 12/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.